|
Volumn 354, Issue 21, 2006, Pages
|
Imatinib mesylate - Uncovering a fast track to adaptive immunity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CD4 ANTIGEN;
CD8 ANTIGEN;
CYTOKINE;
GAMMA INTERFERON;
IMATINIB;
INTERFERON;
INTERLEUKIN 12;
INTERLEUKIN 2;
PERFORIN;
PROTEIN TYROSINE KINASE;
PROTEIN TYROSINE KINASE INHIBITOR;
TOLL LIKE RECEPTOR;
ARTICLE;
CANCER SURVIVAL;
CELL MIGRATION;
CELL PROLIFERATION;
CELL STRUCTURE;
CELLULAR IMMUNITY;
CHRONIC MYELOID LEUKEMIA;
DENDRITIC CELL;
DRUG BINDING;
DRUG EFFECT;
ELECTRON MICROSCOPY;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
IMMUNE RESPONSE;
IN VITRO STUDY;
INNATE IMMUNITY;
INTERFERON PRODUCTION;
KIDNEY CANCER;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MELANOMA;
NATURAL KILLER T CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
STOMACH CANCER;
TUMOR IMMUNITY;
ADOPTIVE TRANSFER;
ANIMALS;
CYTOTOXICITY, IMMUNOLOGIC;
DENDRITIC CELLS;
INTERFERON TYPE II;
INTERFERONS;
KILLER CELLS, NATURAL;
MICE;
NEOPLASMS;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
|
EID: 33646858146
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr061878 Document Type: Article |
Times cited : (17)
|
References (5)
|